SCHEMBL10089940

SCHEMBL10089940

Cc1ccc(Cl)c(C(=O)NCc2ccccc2Cl)c1NC(=O)c1cc(Cn2nnc(C(F)(F)F)n2)nn1-c1ncccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.35
MAPT P10636 3/20 0.35
KMT2A Q03164 4/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
P2RX7 Q99572 1/20 0.34
MEN1 O00255 3/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ANO1 Q5XXA6 1/20 0.33
MAPK8 P45983 1/20 0.33
SLC16A3 O15427 2/20 0.33
SLC16A1 P53985 2/20 0.33
MCTS1 Q9ULC4 2/20 0.33
ROCK2 O75116 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15905605 0.93 HSD17B13 (0.40)
SCHEMBL10090047 0.91 DHODH (0.37) TP53MAPTKMT2AMEN1POLB
SCHEMBL10089984 0.90 MMP13 (0.38) LMNAPOLB
SCHEMBL10089841 0.89 TP53 (0.38) TP53MAPTKMT2AALDH1A1CYP1A2
SCHEMBL10089943 0.88 RIPK1 (0.37) ALDH1A1CYP1A2CYP3A4GAACYP2C19
SCHEMBL10090046 0.88 HSD17B13 (0.41)
SCHEMBL15905608 0.87 GLS (0.38) SLC16A3SLC16A1MCTS1ROCK2
SCHEMBL10089986 0.87 MAPK8 (0.39) TP53MAPTKMT2AALDH1A1CYP1A2
SCHEMBL10089948 0.85 TP53 (0.35) TP53KMT2AP2RX7MEN1MAPK8
SCHEMBL10090049 0.85 MEN1 (0.36) TP53MAPTKMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582695-B1 ANTHRANILIC ACID DIAMIDE DERIVATIVES WITH CYCLICAL SIDE CHAINS BAYER IP GMBH (DE) 2015-09-30 EP disclosed
US-8791143-B2 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2014-07-29 US disclosed
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains DDT, ADCY1, ANTXR2 TP53 3397/4885MAPT 4663/4885KMT2A 961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.